The work you do KEEPS ME ALIVE A personal experience of metastatic
disease, unfunded medication, going public and living on borrowed
time.
Hilary Chung has recently been in the media contributing to the
on-going campaign for the public funding of drugs for advanced breast
cancer which are the internationally recognised standard treatment for
her disease. She will tell her own story of diagnosis, prognosis,
private fundraising and her experience of the full range of treatments
and their side effects, and the implications of being in the public
spotlight. Questions and discussion are encouraged.
Dr Hilary Chung is the founding director of the Global Studies
programme which she continues to run and develop. She is a former
Associate Dean and Head of School (Asian Studies). Her area of
research is Comparative Literature. She speaks six languages and works
and teaches in comparative cultural studies.
She has been living with breast cancer since 2015, and with metastatic
disease since 2017. She raised over $66,000 to pay for the drug
Palbociclib (Ibrance) which is not funded in New Zealand.
This talk is part of the 2019 ABI Tuesday Seminar Series. The seminars
are all open to the public, and there will be a new talk each Tuesday,
from 4-5pm, held at the Auckland Bioengineering House, 70 Symonds St.
To find out more about ABI news and events, subscribe to our
newsletter: www.auckland.ac.nz/supportabi
96
Views
18/09/2019 Last update